Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
暂无分享,去创建一个
Ulrich Budde | M. Dittrich | I. Birschmann | Martin Strüber | A. Reininger | M. Strüber | Bettina Wiegmann | T. Eller | B. Wiegmann | U. Budde | Marcus Dittrich | Ingvild Birschmann | Thomas Eller | Armin J. Reininger
[1] Christoph Benk,et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[2] G. Di Minno,et al. Aspirin resistance, platelet turnover, and diabetic angiopathy: a 2011 update. , 2012, Thrombosis research.
[3] R. Marchant,et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. , 1996, Blood.
[4] R. Hebbel,et al. Activation of endothelial and coagulation systems in left ventricular assist device recipients. , 2009, The Annals of thoracic surgery.
[5] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[6] J. Geiger,et al. Monitoring of clopidogrel action: comparison of methods. , 2005, Clinical chemistry.
[7] D. Danielak,et al. Genetic and non-genetic factors affecting the response to clopidogrel therapy , 2012, Expert opinion on pharmacotherapy.
[8] F. Michal,et al. Effect of the rapid shape change of platelets on the transmission and scattering of light through plasma. , 1971, Nature: New biology.
[9] G. Maurer,et al. Personalized antiplatelet treatment after percutaneous coronary intervention: the MADONNA study. , 2013, International journal of cardiology.
[10] S. Russell,et al. Bleeding complications and blood product utilization with left ventricular assist device implantation. , 2011, The Annals of thoracic surgery.
[11] K. Hornik,et al. A Lego System for Conditional Inference , 2006 .
[12] L. Aledort,et al. Functional changes in platelets during extracorporeal circulation. , 1975, The Annals of thoracic surgery.
[13] S. Schulman,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients , 2005, Journal of thrombosis and haemostasis : JTH.
[14] M. Price,et al. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial. , 2012, Journal of the American College of Cardiology.
[15] M. Slaughter,et al. Acquired von Willebrand Syndrome in Patients With an Axial Flow Left Ventricular Assist Device , 2010, Circulation. Heart failure.
[16] Martin Strueber,et al. Multicenter evaluation of an intrapericardial left ventricular assist system. , 2011, Journal of the American College of Cardiology.
[17] Ranjit John,et al. Bleeding and Thrombosis in Patients With Continuous-Flow Ventricular Assist Devices , 2012, Circulation.
[18] A. Schmaier,et al. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH , 2013, Journal of thrombosis and haemostasis : JTH.
[19] P. Gurbel,et al. Earlier recovery of platelet function after discontinuation of treatment with ticagrelor compared with clopidogrel in patients with high antiplatelet responses , 2011, Journal of thrombosis and haemostasis : JTH.
[20] V. Addonizio. Platelet function in cardiopulmonary bypass and artificial organs. , 1990, Hematology/oncology clinics of North America.
[21] J. Goudemand,et al. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD) , 2008, Journal of thrombosis and haemostasis : JTH.
[22] Roland Hetzer,et al. Retrospective Hemolysis Comparison Between Patients With Centrifugal Biventricular Assist and Left Ventricular Assist Devices , 2011, ASAIO journal.
[23] P. Leprince,et al. HeartMate II left ventricular assist device; early European experience. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[24] P. McCarthy,et al. Hemostatic profiles of HeartMate ventricular assist device recipients. , 1995, ASAIO journal.
[25] D Bergqvist,et al. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients , 2010, Journal of thrombosis and haemostasis : JTH.
[26] Y. Misawa,et al. Platelet damage caused by the centrifugal pump: in vitro evaluation by measuring the release of alpha-granule packing proteins. , 2008, Artificial organs.
[27] G. Esposito. Responsiveness to P2Y12 receptor inhibitors , 2011, Current opinion in cardiology.
[28] L. Nielsen,et al. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). , 2009, Journal of the American College of Cardiology.
[29] M. Olschewski,et al. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation. , 2010, Interactive cardiovascular and thoracic surgery.
[30] C. Schlensak,et al. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart , 2010, Thrombosis and Haemostasis.
[31] W. Kop,et al. Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices , 2009, Nature Clinical Practice Cardiovascular Medicine.
[32] R. Hetzer,et al. Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow MicroMed DeBakey LVAD. , 2000, The Annals of thoracic surgery.
[33] P. Teirstein,et al. Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers. , 2008, The American journal of cardiology.
[34] A. Weyrich,et al. Platelets: signaling cells in the immune continuum. , 2004, Trends in immunology.
[35] R. Davidson,et al. Description of an In Vitro Platelet Function Analyzer-PFA-100™ , 1995, Seminars in Thrombosis & Hemostasis.
[36] Dong Chen,et al. Comparative Analysis of von Willebrand Factor Profiles in Pulsatile and Continuous Left Ventricular Assist Device Recipients , 2010, ASAIO journal.